Literature DB >> 6250796

Use of an octadecylsilica purification method minimizes proteolysis during isolation of porcine and rat relaxins.

J R Walsh, H D Niall.   

Abstract

Previous attempts to purify relaxin from pregnant sow and rat ovaries have led to the identification of multiple components with very similar molecular weights (around 6000 daltons) and similar, but not identical amino acid compositions. It has been unclear whether these multiple forms of relaxin represented different allelic forms (isohormones), intermediates in a prohormone-hormone conversion, different hormones in their own right responsible for effects on different target tissues, or degradation products. We have applied a purification system using adsorption to small octadecylsilica (ODS) columns to reduce drastically the degree of heterogeneity. Both pig and rat relaxins are isolated as single major components with defined amino acid sequences and with minimal contamination by other molecular forms. These findings indicate that the relaxin heterogeneity previously observed is due to proteolysis of a single major stored form during conventional isolation procedures.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250796     DOI: 10.1210/endo-107-4-1258

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

1.  Purification and sequence determination of canine relaxin.

Authors:  D R Stewart; W J Henzel; R Vandlen
Journal:  J Protein Chem       Date:  1992-06

2.  Two forms of murine epidermal growth factor: rapid separation by using reverse-phase HPLC.

Authors:  A W Burgess; J Knesel; L G Sparrow; N A Nicola; E C Nice
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  Studies of the effects of subacute treatment with N-(cyclopropylmethyl)-19-isopentylnororvinol (M320) on timing of parturition in the rat.

Authors:  R G Evans; G E Rice; J E Olley
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.